Ayako Bun - Hyogo Medical University

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Role of Sphingolipids in Cancer Progression and Its Microenvironment in Breast Cancer Patients

Akira Hattori, Masayuki Nagahashi, Aoi Oshiro, Ayumu Mitsuyoshi,Haruka Kanaoka,Ayako Bun,Reiko Fukui, Yukie Fujimoto,Tomoko Higuchi,Arisa Nishimukai, Keiko Murase,Yuichi Takatsuka,Yasuo Miyoshi

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PO2-15-09: Immune Related Cell Fraction in Peripheral Blood and Outcomes of Advanced Breast Cancer Patients Treated with Eribulin

Masayuki Nagahashi,Ayako Bun,Mamiko Kuroiwa,Miki Komatsu,Sayaka Urano,Yukie Fujimoto, Aoi Oshiro, Ayumu Mitsuyoshi,Haruka Kanaoka,Akira Hattori,Reiko Fukui,Tomoko Higuchi,Arisa Nishimukai,Keiko Murase,Yuichi Takatsuka,Yasuo Miyoshi

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PO3-13-04: the Role of Sphingolipids in Cancer Progression and Its Microenvironment in Breast Cancer Patients

Akira Hattori,Masayuki Nagahashi, Aoi Oshiro, Ayumu Mitsuyoshi,Haruka Kanaoka,Ayako Bun,Reiko Fukui,Yukie Fujimoto,Tomoko Higuchi,Arisa Nishimukai,Keiko Murase,Yuichi Takatsuka,Yasuo Miyoshi

Cancer Researchno. 9_Supplement (2024): PO3-13

引用0浏览0引用

Abstract P5-12-02: Germline Variants Detected by Next-Generation Sequencing-Based Multigene Panel Testing in Patients with Suspected Hereditary Breast Cancer at a University Hospital in Japan

Yusa Atake,Masayuki Nagahashi,Haruka Kanaoka,Akira Hattori,Ayako Bun,Reiko Fukui,Hiromi Ozawa,Yukie Fujimoto,Tomoko Higuchi,Michiko Imamura,Keiko Murase,Yuichi Takatsuka, Mina Kashima, Chiho Okada, Chinatsu Kinjo, Mikako Miyata, Ayako Miyazaki,Mako Ueda,Hiroshi Tsubamoto,Hideaki Sawai,Yasuo Miyoshi

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Baseline Interleukin-6 is a Prognostic Factor for Patients with Metastatic Breast Cancer Treated with Eribulin

Ayako Bun,Masayuki Nagahashi,Mamiko Kuroiwa,Miki Komatsu,Yasuo Miyoshi

Breast cancer research and treatmentno. 3 (2023): 575-583

引用1浏览0WOS引用

Abstract P4-07-26: Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores

Haruka Kanaoka,Masayuki Nagahashi,Eri Ishikawa,Ayako Bun,Reiko Fukui,Hiromi Ozawa,Tomoko Higuchi,Keiko Natori,Michiko Imamura,Yuichi Takatsuka,Yasuo Miyoshi

Cancer Research（2022）

引用0浏览0引用

Absolute Lymphocyte Count is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated with CDK4/6 Inhibitors

Haruka Kanaoka,Masayuki Nagahashi, Yusa Atake,Akira Hattori,Ayako Bun,Reiko Fukui,Hiromi Ozawa,Yukie Fujimoto,Tomoko Higuchi,Keiko Natori,Michiko Imamura,Keiko Murase,Yuichi Takatsuka,Yasuo Miyoshi

Anticancer Research/Anticancer research（2022）

引用3浏览0WOS引用

Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores

Haruka Kanaoka,Masayuki Nagahashi,Eri Ishikawa,Ayako Bun,Reiko Fukui,Hiromi Ozawa,Tomoko Higuchi,Keiko Natori,Michiko Imamura,Yuichi Takatsuka,Yasuo Miyoshi

CANCER RESEARCH（2022）

引用0浏览0引用

Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor

Hiromi Ozawa,Tomoko Higuchi,Yukie Fujimoto,Ayako Bun,Reiko Fukui,Haruka Kanaoka,Masayuki Nagahashi,Kazuhiro Kitajima,Koichiro Yamakado,Yasuo Miyoshi

Anticancer Res（2022）

引用2浏览0WOS引用

Low Levels Of Interleukin-6 At Baseline Were Significantly Associated With Improved Overall Survival Of Patients Treated With Eribulin For Locally Advanced Or Metastatic Breast Cancer

Ayako Bun,Natsuko Inoue,Yoshimasa Miyagawa,Reiko Fukui,Yukie Fujimoto,Tomoko Higuchi,Atsushi Sata,Hiromi Ozawa,Michiko Imamura,Yasuo Miyoshi

CANCER RESEARCH（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn